Pharmacological interventions in Alzheimer's disease (AD) are likely to be more efficacious
if administered early in the course of the disease, foregoing the spread of irreversible …

Given the failure to develop disease-modifying therapies for Alzheimer's disease (AD),
strategies aiming at preventing or delaying the onset of the disease are being prioritized …

Alzheimer's disease is becoming a growing problem increasing at a tremendous rate.
Serotonin 5-HT 6 receptors appear to be a particularly attractive target from a therapeutic …

As currently postulated, a complex treatment may be key to an effective therapy for
Alzheimer's disease (AD). Recent clinical trials in patients with moderate AD have shown a …

Psychedelics have traditionally been used for spiritual and recreational purposes, but recent
developments in psychotherapy have highlighted their potential as therapeutic agents …

Antagonism of the 5-HT 6 receptor is a promising approach for the symptomatic treatment of
Alzheimer's disease (AD). There is compelling preclinical evidence for the procognitive …

There is recognition that both stress and immune responses are important factors in a variety
of neurological disorders. Moreover, there is an important role of several neurotransmitters …

The gut microbiota have gained much scientific attention recently. Apart from unravelling the
taxonomic data, we should understand how the altered microbiota structure corresponds to …

Alzheimer's disease (AD) is the most common cause of dementia in elderly people.
Research focused on identifying compounds that restore cognition and memory in AD …

The monoaminergic systems are the target of several drugs for the treatment of mood, motor
and cognitive disorders as well as neurological conditions. In most cases, advances have …